Navigation Links
Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
Date:4/30/2008

nce. In 2004, he was named Chief Scientific Officer of the Year by IBC Conferences.

Dr. Dohlsten, 49, previously was Executive Vice President within Pharmaceutical Research & Development/Medicine at Boehringer Ingelheim. He was responsible for leading the company's worldwide pharmaceutical research in the U.S., Canada, Germany, Italy, Austria and Japan - with major programs in seven therapeutic areas including respiratory, inflammation/immunology, oncology, virology, cardiovascular, metabolism and CNS. In addition, he was a member of the corporate management team responsible for reviewing all worldwide development projects and licensing opportunities. Prior to joining Boehringer Ingelheim, Dr. Dohlsten spent more than 15 years in various leadership roles in pharmaceutical research including positions with AstraZeneca and Pharmacia & Upjohn.

Dr. Dohlsten earned his Ph.D. in tumor immunology and M.D. from the University of Lund in Sweden. He also studied virology and cell biology at the Weizmann Institute in Israel and has been appointed as Adjunct Professor in Immunology at the Medical Faculty in Lund.

"We look forward to Dr. Dohlsten's leadership as we work together to continue our success at Wyeth Research," says Bernard Poussot. "His experience with industry in a broad range of therapeutic areas, and his vision going forward, match well with our scientific objectives. We know Mikael's global experience and perspective will be an inspiration to Wyeth's outstanding research teams."

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Wyeth Chairman Robert Essner Announces June 27 Retirement
2. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
3. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
4. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
5. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
6. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
7. Wyeth Announces Executive Change in Finance Organization
8. Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
9. Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
11. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Industry leaders from around the world ... Oak Ridge National Laboratory’s Biosurveillance Symposium on ... Hilton Alexandria Mark Center. Held in conjunction will ... on June 18 - 19. , Join the ... Applied Research Associates, ARA, AttaGene, Battelle, Benedictine University, ...
(Date:5/22/2013)... iLuv Creative Technology, the premier provider of ... lifestyle, announces they are now shipping MultiCharger-X, an easy ... devices efficiently. Winner of the 2013 internationally recognized iF ... MultiCharger-X is revolutionizing the way businesses, schools, and medical ... , MultiCharger-X (iAD910) combines the best of ...
(Date:5/22/2013)... Cambridge Semantics was one of just 22 ... on Capitol Hill, hosted by The Data Transparency ... to showcase how innovative data management applications can address the ... Act). , Originally introduced in 2011 by Committee ... Mark Warner (D-VA ), the DATA Act is designed ...
(Date:5/22/2013)... York (PRWEB) May 22, 2013 ... 3rd Annual Disruptive Innovations to Advance Clinical Trials conference ... Plaza Hotel in Boston, MA. , Disruptive thinkers ... Pharmaceuticals and more share bold approaches to reduce expensive ... , “Disruptive innovation needs to be big, or novel, ...
Breaking Biology Technology:Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 2Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 3Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 4Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 5iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2
... Better Understanding ... 15 Results from the Global Longitudinal,study of Osteoporosis in ... do not believe they are at a higher risk of,fractures ... than,60,000 women over age 55 and was presented today at ...
... September 15 , - Oncentra(R) RT Viewer* ... September 14-18 and ASTRO 2008, Boston, USA, September,21-24, ... today,announced the market release of Oncentra RT Viewer. ... allows clinicians to review,radiotherapy plans that are generated ...
... 12 Fougera, a division of Nycomed,US Inc., ... Cream USP,1%. The generic formulation compares to Taro,s ... sizes: 15g tubes (NDC # 0168-0133-15), 30g tubes,(NDC ... "The approval of Clotrimazole Cream is another ...
Cached Biology Technology:Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures 2Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures 3Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy 2
(Date:5/21/2013)... Chicago College of Medicine will study gender differences in how ... source -- and how changes in fat metabolism play a ... grant from the National Heart, Lung and Blood Institute. , ... energy. These changes may play a major role in the ... women, says E. Douglas Lewandowski, director of the UIC Center ...
(Date:5/21/2013)... of insulin action in cells in precise detail like ... what goes wrong in diabetes. , The breakthrough ... from Sydney,s Garvan Institute of Medical Research, is now ... journal Cell Metabolism . , First discovered in ... in the body because it helps us lower blood ...
(Date:5/20/2013)... about the effect of physical education (PE) on child ... that increasing the amount of time that elementary schoolchildren ... , The study represents some of the first evidence ... and is forthcoming in the Journal of Health ... study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3Gym class reduces probability of obesity, study finds for first time 2
... time impact the delivery of drugs and explain a ... nanoparticles that can penetrate a cell without poking a ... The key to their approach? Stripes. The team ... two different kinds of molecules can quickly pass into ...
... Spanish . Networks for radiological monitoring ... environment and detect possible incidents. The PhD thesis ... the University of the Basque Country provides a ... radiological incidents caused externally. Most countries ...
... independent review of social and ethical challenges associated with ... published today (9 June). The report, commissioned by the ... Society Strategy Panel, is part of its programme to ... rapidly emerging area of science and technology. Embargoed copies ...
Cached Biology News:MIT: Stripes key to nanoparticle drug delivery 2More sensitive radiology monitoring in the Basque Country 2More sensitive radiology monitoring in the Basque Country 3Synthetic Biology: funders move to address social and ethical challenges 2